Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pancreatic cancer models in mice were developed to track tumor growth and characteristics. This research defines stages for preclinical models to improve testing of new pancreatic cancer treatments.
Area Of Science
- Oncology
- Preclinical Research
- Cancer Biology
Background
- Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with poor survival rates.
- Late diagnosis is common due to the pancreas's location and lack of early symptoms.
- Most patients present with advanced disease, necessitating effective preclinical models for therapy testing.
Purpose Of The Study
- To establish and characterize standardized, cell-based orthotopic pancreatic cancer models in mice.
- To identify key progression features using ultrasound imaging and histology.
- To propose growth parameter-based staging for preclinical PDAC models.
Main Methods
- Standardized induction of orthotopic pancreatic cancer models using BxPC-3 and Panc-1 cell lines in mice.
- Ultrasound imaging to monitor tumor growth and anatomical location.
- Histological analysis to assess pancreatic stellate cells, fibroblasts, and collagen levels.
Main Results
- Early-stage tumors were confined to the pancreas.
- Tumor infiltration of the omentum occurred by weeks 5-7.
- Late stages exhibited extensive growth, metastasis, and increased stromal components.
Conclusions
- The study provides a framework for staging orthotopic pancreatic cancer models based on growth parameters.
- These defined stages can enhance the reliability of preclinical drug efficacy testing.
- Standardized models are crucial for advancing pancreatic cancer therapeutics.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
